What is the clinical evidence for using Dimethyl Sulfoxide (DMSO) as a penetration enhancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Evidence for DMSO as a Penetration Enhancer

DMSO is an effective penetration enhancer for topical drug delivery with established clinical evidence, though its use should be limited to concentrations below 10% to minimize adverse reactions while maintaining efficacy. 1

Mechanism and Efficacy

DMSO functions as a pharmaceutical penetration enhancer through several mechanisms:

  • Facilitates transdermal delivery of both hydrophilic and lipophilic medications 1
  • Enables localized drug delivery by enhancing skin permeation 1
  • Has demonstrated a 4-fold increase in estradiol skin permeation compared to controls in transdermal patch formulations 2
  • Serves as an effective vehicle for topical administration of NSAIDs 1

Clinical Applications

DMSO has established clinical uses as a penetration enhancer:

  • Used in FDA-approved diclofenac sodium topical solution for osteoarthritis 1
  • Approved in Europe for idoxuridine topical solution for herpes zoster treatment 1, 3
  • Enhances photodynamic therapy efficacy in dermatological applications, with DMSO + EDTA increasing clinical clearance rates from 67% to 90% for nodular basal cell carcinomas < 2mm thick 4
  • Can be combined with 23% ALA gel and red light PDT for treating sarcoidosis 4

Dosing and Administration Guidelines

The concentration and volume of DMSO are critical factors affecting both efficacy and safety:

  • The organic solvent portion (DMSO) in formulations should not exceed 10% for any route of administration 5
  • Starting with lower concentrations (around 50%) is recommended to minimize skin irritation 4
  • For transdermal patches, DMSO concentrations should be carefully controlled during manufacturing (drying at 35-40°C) to retain effective amounts while removing other solvents 2

Safety Profile and Adverse Reactions

DMSO has a well-documented safety profile with mostly transient adverse effects:

  • Most common adverse reactions are gastrointestinal and skin-related 6
  • Adverse reactions are dose-dependent, with higher concentrations causing more side effects 6
  • Local reactions include erythema, skin rash, and pruritus, especially at higher concentrations 4
  • DMSO appears safe when used in small doses 6
  • Can cause a characteristic garlic-like odor on breath and skin after application

Clinical Considerations and Precautions

Important considerations when using DMSO include:

  • Safety of DMSO in combination with other drugs is not fully established, with reported neurotoxic interactions with sulindac 4, 3
  • Local erythema may affect correct evaluation of tissue damage 4
  • DMSO is not readily acceptable for clinical use in some formulations due to potential irritation 5
  • Avoid application to open wounds or broken skin 4
  • Use with caution in patients with known hypersensitivity or severe cardiovascular disease 4

Comparative Efficacy

When comparing DMSO to other penetration enhancers:

  • Oleic acid has shown similar clearing effects to DMSO in experimental studies 7
  • Oleic acid may be considered as an alternative enhancer with potentially fewer safety concerns 7
  • DMSO has the additional benefit of inhibiting drug recrystallization in transdermal formulations, improving product stability 2

DMSO's long history in pharmaceutics has generated robust safety and efficacy data over the past three decades, supporting its clinical use as a penetration enhancer when properly formulated and administered 1.

References

Research

Medical use of dimethyl sulfoxide (DMSO).

Reviews in clinical & basic pharmacology, 1985

Guideline

Pain Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.